Formulation and preliminary in vivo testing of rufloxacin-cyclodextrin ophthalmic solutions

Journal of Inclusion Phenomena

Volumn 44, Issue 1-4, 2002, Pages 173-176

  Cappello, Brunella ^a   Iervolino, Maria ^a   Miro, Agnese ^a   Chetoni, Patrizia ^b   Burgalassi, Susi ^b   Saettone, M Fabrizio ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

cyclodextrin; cyclodextrin; Aqueous humor pharmacokinetics; Hydroxypropyl methylcellulose; Hydroxypropyl cyclodextrin; Rabbits; Rufloxacin; Solubilization

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; EYE DROPS; GAMMA CYCLODEXTRIN; HYDROXYPROPYLMETHYLCELLULOSE; RUFLOXACIN;

ANIMAL EXPERIMENT; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SOLUBILITY; MALE; NONHUMAN; PH; RABBIT; TEMPERATURE SENSITIVITY;

EID: 0346396026     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023050814697     Document Type: Conference Paper

References (10)

1. R. Mattina, G. Bonfiglio, C.E. Cocuzza, G. Gulisano, M. Cesana, and B.P. Imbimbo: Chemotherapy 37, 389 (1991).
2. P.Y. Robert and J.P. Adenis: Drugs 61, 175 (2001).
3. T. Loftsson and M.E. Brewster: J. Pharm. Sci. 85, 1017 (1996).
4. K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 98, 2045 (1998).
5. T. Loftsson and T. Järvinen: Adv. Drug Deliv. Rev. 36, 59 (1999).
6. T. Loftsson, H. Fridriksdóttir, A.M. Sigurdardóttir, and H. Ueda: Int. J. Pharm. 110, 169 (1994).
7. P. Saarinen-Savolainen, T. Järvinen, K. Araki-Sasaki, H. Watanabe, and A. Urtti: Pharm. Res. 15, 1275 (1998).
8. T. Higuchi and K.A. Connors: Adv. Anal. Chem. Instrum. 4, 117 (1965).
9. R. Beck, J. Keyserlingk, U. Fisher, R. Guthoff, and B. Drewelow: Graefe's Arch. Clin. Exp. Ophthalmol. 237, 89 (1999).
10. B. Cappello, C. Carmignani, M. Iervolino, M.I. La Rotonda, and M.F. Saettone: Int. J. Pharm. 213, 75 (2001).